| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Amphotericin B| 1 | 1990 | Amphotericin B: current understanding of mechanisms of action. | 
| + | - | nl | Antimicrob Agents Chemother 34(2):183-8 (1990) |
| 2 | 1990 | Amphotericin B: delivery systems. |
| + | - | nl | Antimicrob Agents Chemother 34(3):381-4 (1990) Brajtburg J |
| 3 | 2002 | Amphotericin B: spectrum and resistance. |
| + | - | nl | J Antimicrob Chemother 49 Suppl 1(-):7-10 (2002) |
| 4 | 2008 | Liposomal amphotericin B: what is its role in 2008? |
| + | - | nl | Clin Microbiol Infect 14 Suppl 4():71-83 (2008) Lanternier F |
| 5 | 2008 | Amphotericin B lipid preparations: what are the differences? |
| + | - | nl | Clin Microbiol Infect 14 Suppl 4():25-36 (2008) Adler-Moore JP |
| 6 | 2003 | Organization of antibiotic amphotericin B in model lipid membranes. A mini review. |
| + | - | nl | Cell Mol Biol Lett 8(1):161-70 (2003) Gruszecki WI |
| 7 | 1995 | Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties. |
| + | - | nl | J Am Soc Nephrol 6(2):154-64 (1995) |
| 8 | 1973 | On the anatomy of amphotericin B-cholesterol pores in lipid bilayer membranes. |
| + | - | nl | Kidney Int 4(5):337-45 (1973) |
| 9 | 2002 | Amphotericin B nephrotoxicity. |
| + | - | nl | J Antimicrob Chemother 49 Suppl 1(-):37-41 (2002) |
| 10 | 2002 | Overview of the lipid formulations of amphotericin B. |
| + | - | nl | J Antimicrob Chemother 49 Suppl 1(-):31-6 (2002) |
